Senior Partner Newmarket Strategy. Former Commercial Medicines Director - NHSE. Medicines and healthcare innovation and Fulham FC mostly. All views my own.
The medicines & conditions can be a bit tricky to say😁… but the simple fact is that the NHS is securing innovative treatments for frontline staff to offer first class care to people across the country. I was delighted to share a few stories at the NHS Board meeting last week
My review of UK commercial clinical trials is published today: gov.uk/government/publicatio…. I'm incredibly grateful to the doctors, nurses, researchers, companies, public servants, charities and patients who contributed.
I'm delighted that pembrolizumab with chemotherapy will be available to women with triple negative breast cancer following another NHS deal. This will benefit up to 1,600 patients each year – like NHS nurse, Lauren who is now almost five years cancer free. bbc.co.uk/news/health-635401…
Today, @NHSEngland in partnership with @NICEComms, launch the Innovative Medicines Fund - the Fund will continue NHS momentum as an adopter of medical innovation through agreements that also safeguard value for taxpayers. bbc.in/3mn3ltK
Hundreds of people with the most common form of an aggressive lung cancer could survive twice as long, thanks to a drug now available on the NHS.
The drug, durvalumab, can double the overall time someone can survive from two and a half to five years. 👉 england.nhs.uk/2022/05/hundr…
ALT This drug will be a huge boost for lung cancer patients across England and is also the latest in a long list of innovative, targeted cancer treatments secured by the NHS.
With partners @NICEComms and @DHSCgovuk we’ve taken a big step with our #AMR pilot where the UK is really ‘punching above its weight’ to provide a model for health systems Worldwide. bbc.in/3KAWPKk
A revolutionary tumour-stopping drug for lung cancer will be made available to anyone who is eligible, thanks to a new deal announced today.
Read how hundreds more patients will now be able to receive this first-of-its-kind treatment. ➡️ england.nhs.uk/2022/03/hundr…
ALT NHS Chief Executive Amanda Pritchard quote reads: 'From life-changing drugs for cystic fibrosis to new treatments for sickle cell disease, this is the latest in a long list of deals we have struck to provide the latest cutting-edge therapies for patients - at a price that is affordable for the taxpayer'
I am pleased that dostarlimab will be available from today via the Cancer Drugs Fund. This is another example of where the CDF will fast-track the most clinically promising treatments to patients whilst further data is collected, which is great news for patients and clinicians
A 30-minute treatment, the first of its kind for advanced womb cancer, is being rolled out for women across England.
Find out how patients with advanced or recurrent endometrial cancer will be offered this life-extending drug, called dostarlimab. ➡️ england.nhs.uk/2022/02/new-l…
ALT Professor Stephen Powis quote reads: 'The NHS has continued to treat cancer patients throughout the pandemic and as we continue to expand our arsenal of treatments against all cancers, please do come forward and get checked if you have a worrying sign or symptom.'
Great news for NHS patients - thanks to the @NHSEngland, @_RocheUK, @NICEComms and @MHRAgovuk working together, the promising lung cancer drug, atezolizumab can be fast-tracked to people with #NSCLC following its licensing through #ProjectOrbis
Thousands of lung cancer patients in England will be fast-tracked a ground-breaking new drug, atezolizumab, which can significantly reduce the risk of cancer returning.
Read more about the cutting-edge treatment. ➡️ england.nhs.uk/2022/01/lung-…
ALT Amanda Pritchard, NHS Chief Executive quote reads, 'By making atezolizumab available at the earliest opportunity, NHS patients now have a very exciting new treatment, which has the potential to dramatically reduce their risk of cancer relapse.'
An important call to arms on AMR. Read more about what NHS England and partners are doing to show leadership in this area bit.ly/3Ij6BiE#TogetherForAntibiotics
The 'silent pandemic' is not silent anymore.
New data, published in today’s #Lancet, show the true global cost of #AMR.
We must use these data as a warning signal to spur on action at every level.
#AMRSOS 👉 bit.ly/3nBEvas
Delighted to announce @NHSEngland has agreed a deal with @Teva_UK to secure a generic version of the drug sapropterin for #PKU patients of all ages in England.
After an active 12 months, this latest deal paves the way for 100s of people to benefit from treatment in the New Year
Our NHS commercial medicines deals put innovative treatments into the hands of amazing front-line staff like Dr Elizabeth Wraige. It’s great to hear how this third NHS agreement for new SMA drugs in less than three years is enabling such leaps in patient care & treatment
‘This is fantastic news for all the families and children affected by this condition.’
Dr Elizabeth Wraige, Consultant Paediatric Neurologist, explains more about what the drug Risdiplam means for patients with spinal muscular atrophy. Read more. ➡️ england.nhs.uk/2021/11/nhs-d…
Excellent news that patients with sickle cell disease will be able to access the first new drug in over 20 years, crizanlizumab. More from @AmandaPritchard here:
The first sickle cell treatment in over 20 years will be available to thousands of patients thanks to a new deal announced today.
The revolutionary treatment will help save lives, improve quality of life and reduce A&E trips by almost half. england.nhs.uk/2021/10/nhs-a…
🎥: @BBCNews
Fantastic achievement from the Commercial Medicines Unit who have won the 'Procurement Team of the Year Award’ at the @GOAwardsNews. This award reflects the hard work undertaken to ensure patients with Haemophilia A can access treatments whilst safeguarding the NHS budget
The NHS has today begun the world's largest trial of a new blood test that detects more than 50 types of cancer before symptoms appear. By finding cancer early, we have the best chance of treating it and giving people the best possible chance of survival.
This is one of the most exciting breakthroughs in lung cancer in 20 years.
Sotorasib is a precision treatment – now approved in England, but it's a milestone 40 years in the making, with research by @CR_UK and many others.
news.cancerresearchuk.org/20…
Delighted that the NHS will now be able to offer patients #inclisiran, a treatment to lower cholesterol, due to our NHS-first 'population health' deal with @Novartis which makes the drug available to a large-scale patient group at a price fair to taxpayers england.nhs.uk/2021/09/nhs-c…
'My Kaftrio journey has been incredible not just for me, but to start a family as well.'
Laura is one of thousands of people with cystic fibrosis in England who has benefited from a life-changing drug — one year on since it was made available on the NHS. england.nhs.uk/2021/08/mum-g…
It's fantastic to see how Kaftrio is helping cystic fibrosis patients, and giving hope, one year after the drug was available following @NHSEngland's deal. Let's hope more people around the world can now benefit from this groundbreaking medicine. google.com/amp/s/inews.co.uk…